Provectus Biopharmaceuticals - PVCT Short Interest Ratio & Short Volume

Short interest is the volume of Provectus Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of January 15th, traders have sold 9,700 shares of PVCT short. Learn More on Provectus Biopharmaceuticals' current short interest.

Provectus Biopharmaceuticals saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 9,700 shares, an increase of 9,600.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Provectus Biopharmaceuticals: Bolt Biotherapeutics, Inc. (7.22%), SCYNEXIS, Inc. (2.85%), Hepion Pharmaceuticals, Inc. (0.73%), Infinity Pharmaceuticals, Inc. (1.32%), Applied Therapeutics, Inc. (0.44%), Pyxis Oncology, Inc. (4.10%), Unity Biotechnology, Inc. (3.99%), Bioxytran, Inc. (0.02%), Lantern Pharma Inc. (2.01%), and Alzamend Neuro, Inc. (4.54%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.43 billion), T. Rowe Price Group, Inc. ($2.26 billion), Coinbase Global, Inc. ($2.19 billion), Etsy, Inc. ($1.78 billion), Paramount Global ($1.77 billion), Old Dominion Freight Line, Inc. ($1.69 billion), United Rentals, Inc. ($1.53 billion), American Airlines Group Inc. ($1.52 billion), PG&E Co. ($1.48 billion), and Voya Financial, Inc. ($1.47 billion). View all of the most shorted stocks.

Short selling PVCT is an investing strategy that aims to generate trading profit from Provectus Biopharmaceuticals as its price is falling. PVCT shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Provectus Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PVCT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PVCT, twice per month. The most recent reporting period available is January, 15 2023.